Astrid Blicher Schelde

Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study

Christian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm et al. · medRxiv · 2021 · 160 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study

Mie Agermose Gram, Hanne‐Dorthe Emborg, Astrid Blicher Schelde et al. · PLoS Medicine · 2022 · 155 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

GLP-1 based therapies and disease course of inflammatory bowel disease

Marie Villumsen, Astrid Blicher Schelde, Espen Jimenez‐Solem et al. · EClinicalMedicine · 2021 · 88 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +14

Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study

Katrine Finderup Nielsen, Ida Rask Moustsen‐Helms, Astrid Blicher Schelde et al. · PLoS Medicine · 2022 · 57 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study

Mie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde et al. · PLoS Medicine · 2021 · 39 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17